Study S002478

Study on the Efficacy and Safety of PLLA Injections for Improving Facial Laxity Following GLP-1 Analog Therapy

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07478198
Acronym: PLLA-GLP-1
Study type: INTERVENTIONAL
Masking: NONE
Status: ENROLLING_BY_INVITATION
Enrollment: 22
Start: 2025-07-03
Primary completion: 2026-08-31
Lead sponsor: Shanghai Punan Hospital of Pudong New District
Conditions: Facial Skin Laxity
Interventions: DEVICE:PLLA injection
Results posted: FALSE
Individual participant data sharing: UNDECIDED
Secondary identifiers: OTHER:PuNanPLLA-001

Registered primary outcomes

WSRS (Wrinkle Severity Rating Scale) Assessment [At screening, before each treatment session, and at 4, 12, 24 and 48 weeks after the final treatment]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0010769	The rise of "Ozempic Face": Analyzing trends and treatment challenges associated with rapid facial weight loss induced by GLP-1 agonists. Mansour MR, Journal of plastic, reconstructive & aesthetic surgery : JPRAS	2024	Commentary	PMID 39098289 DOI	registry reference BACKGROUND:39098289